Close Menu

NEW YORK (GenomeWeb) – Paradigm Diagnostics announced today that it has secured an additional $3 million in funding as part of a planned $7 million Series B round of financing.

The investment was made by New Science Ventures and follows a $3.5 million investment led by Mesa Verde Venture Partners in November. New Science Ventures Partner Grace Colón also joined Paradigm's board.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
10
Sponsored by
Congenica II

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.